secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARIMED INC. (MRMD)
CIK:        0001522767
Form:       8-K
Filed at:   2021-08-19T23:59:59+00:00
Accession:  0001493152-21-020701
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MariMed Q2 revenue $32.6M (+239% YoY); raises FY2021 guidance to $118M revenue, $32M EBITDA
--------------------------------------------------------------------------------

- Revenue $32.6M, up 239% YoY and 32% QoQ; net income $7.6M vs loss $1.1M in Q2 2020.
- EBITDA $12.3M (+440% YoY); Adjusted EBITDA $13.9M (43% margin).
- Raises FY2021 guidance: revenue to $118M (from $100M), EBITDA to $32M (from $30M); first-time Adj. EBITDA guide of $42M.
- Positive operating cash flow $10.8M; working capital $20.9M, up $7.2M from Q1.
- Growth driven by wholesale in MA, retail in MA/IL, and branded product licensing in six states.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1522767/000149315221020701/0001493152-21-020701-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1522767/000149315221020701/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-020701

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer